Presence of t(8;21)(q22;q22) in myeloperoxidase-positive, myeloid surface antigen-negative acute myeloid leukemia

American Journal of Clinical Pathology

Volumn 107, Issue 1, 1997, Pages 68-73

  Arber, Daniel A ^a   Glackin, Carlotta ^a   Lowe, Gina ^a   Medeiros, L Jeffrey ^a   Slovak, Marilyn L ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Acute myeloid leukemia; Immunophenotyping; Myeloid antigens; t(8; 21)

Indexed keywords

CD14 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CYTARABINE; DAUNORUBICIN; HLA DR ANTIGEN; MEMBRANE ANTIGEN; MICROSOMAL AMINOPEPTIDASE; MYELOPEROXIDASE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW BIOPSY; BONE MARROW TRANSPLANTATION; CASE REPORT; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 8; CYTOGENETICS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; KARYOTYPE; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031052164     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/107.1.68     Document Type: Article

References (20)

1. Bennett JM, Catovsky D, Daniel M, et al. Proposals for the classification of the acute leukemias. Br J Haematol. 1976;33:451-158.
2. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Ann Intern Med. 1985;103:626-629.
3. Lo Coco FL, Pasqualetti D, Lopez M, et al. Immunophenotyping of acute myeloid leukaemia: relevance of analysing different lineage-associated markers. Blut. 1989;58:235-240.
4. Bennett JM, Catovsky D, Daniel M, et al. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO). Br J Haematol. 1991;78:325-329.
5. Zeleznik-Le NJ, Nucifora G, Rowley JD. The molecular biology of myeloproliferative disorders as revealed by chromosomal abnormalities. Semin Hematol. 1995;32:201-219.
6. Swansbury GJ, Lawler SD, Alimenia G, et al. Long-term survival in acute myelogenous leukemia: a second follow-up of the Fourth International Workshop on Chromosomes in Leukemia. Cancer Genet Cylogenet. 1994;73:1-7.
7. Seshi B, Kashyap A, Bennett JM. Acute myeloid leukaemia with an unusual phenotype: myeloperoxidase(+), CD13(-), CD14(-) and CD33(-). Br J Haematol. 1992;81:374-377.
8. Drexler HG, Coustan-Smith E, Gignac SM, et al. In vitro induction of myeloid surface markers in a rare case of acute leukemia. Am J Hematol. 1987;25:441-448.
9. Downing JR, Head DR, Curcio-Brint AM, et al. An AML/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;21)(q22;q22) translocation. Blood. 1993; 81:2860-2865.
10. Chomczynski P, Sacchi N. Single-step method for RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
11. Ng S, Gunning P, Eddy R, et al. Evolution of the functional human β-actin gene and its multi-pseudogene family: conservation of noncoding regions and chromosomal dispersions of pseudogenes. Mol Cell Biol. 1985;5:2720-2732.
12. Tsuchiya H, El Sonbaty SS, Nagano K, et al. Acute myeloblastic leukemia (ANLL-M2) with t(8;21)(q22;q22) variant expressing lymphoid but not myeloid antigens with a high number of G-CSF receptors. Leuk Res. 1993;17:375-377.
13. Khalil SH, Jackson JM, Qari MH, Pyle H. Acute myeloblastic leukemia (AML-M2) expressing CD19 B-cell lymphoid antigen without myeloid surface antigens. Leuk Res. 1994;18:145.
14. Hanson CA, Abaza M, Sheldon S, et al. Acute biphenotypic leukaemia: immunophenotypic and cytogenetic analysis. Br J Haematol. 1993;84:49-60.
15. Reading CL, Estey EH, Huh YO, et al. Expression of unusual immunophenotype combinations in acute myelogenous leukemia. Blood. 1993;81:3083-3090.
16. Hurwitz CA, Raimondi SC, Head D, et al. Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children. Blood. 1992;80:3182-3188.
17. Kita K, Nakase K, Miwa H, et al. Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood. 1992;80:470-477.
18. Second MIC Cooperative Study Group. Morphologic, immunologic, and cytogenetic (MIC) working classification of the acute myeloid leukemias: report of the workshop held in Leuven, Belgium, September 15-17, 1986. Cancer Genet Cytogenet. 1988;30:1-15.
19. Nucifora G, Rowley JD. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood. 1995;86:1-14.
20. Bene MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias. Leukemia. 1995;9:1783-1786.